GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CVR Medical Corp (OTCPK:CRRVF) » Definitions » Debt-to-EBITDA

CVR Medical (CVR Medical) Debt-to-EBITDA : -0.92 (As of Sep. 2022)


View and export this data going back to 2016. Start your Free Trial

What is CVR Medical Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

CVR Medical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2022 was $0.60 Mil. CVR Medical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2022 was $0.27 Mil. CVR Medical's annualized EBITDA for the quarter that ended in Sep. 2022 was $-0.95 Mil. CVR Medical's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2022 was -0.92.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for CVR Medical's Debt-to-EBITDA or its related term are showing as below:

CRRVF's Debt-to-EBITDA is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.26
* Ranked among companies with meaningful Debt-to-EBITDA only.

CVR Medical Debt-to-EBITDA Historical Data

The historical data trend for CVR Medical's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CVR Medical Debt-to-EBITDA Chart

CVR Medical Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -0.03 -6.25 -0.44

CVR Medical Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.86 -0.14 -1.74 -1.22 -0.92

Competitive Comparison of CVR Medical's Debt-to-EBITDA

For the Medical Devices subindustry, CVR Medical's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CVR Medical's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CVR Medical's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where CVR Medical's Debt-to-EBITDA falls into.



CVR Medical Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

CVR Medical's Debt-to-EBITDA for the fiscal year that ended in Dec. 2021 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.501 + 0.273) / -1.745
=-0.44

CVR Medical's annualized Debt-to-EBITDA for the quarter that ended in Sep. 2022 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.599 + 0.274) / -0.948
=-0.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Sep. 2022) EBITDA data.


CVR Medical  (OTCPK:CRRVF) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


CVR Medical Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of CVR Medical's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


CVR Medical (CVR Medical) Business Description

Traded in Other Exchanges
N/A
Address
221 West Esplanade, c/o Suite 409, North Vancouver, Vancouver, BC, CAN, V7M 3J3
CVR Medical Corp is a medical device company. The company commercializing its Carotid Stenotic Scan (CSS), a patented, diagnostic tool that utilizes subsonic, infrasonic, and low-frequency sound wave analysis technology to detect and measure carotid arterial stenosis.

CVR Medical (CVR Medical) Headlines

No Headlines